Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail, Xibrom and Nevanac in Patients Undergoing Phacoemulsification

NCT01021761 is registered in ClinicalTrials.gov with Frank A. Bucci, Jr., M.D. as lead sponsor.

NCT NCT01021761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01021761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail, Xibrom and Nevanac in Patients Undergoing Phacoemulsification
Lead sponsor
Frank A. Bucci, Jr., M.D.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
January 31, 2010
Enrollment
126 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cataracts